Propofol, a widely used anesthetic, is a significant segment within the injectable drug market. Its primary application is for the induction and maintenance of general anesthesia, as well as sedation for procedures in critical care settings [1].
What is Propofol and How is it Used?
Propofol is an intravenous anesthetic agent administered by healthcare professionals for sedation and general anesthesia [2]. It works by enhancing the effects of GABA, a neurotransmitter that inhibits brain activity, leading to a rapid onset of sedation or unconsciousness [3]. Its short duration of action and rapid recovery profile make it a preferred choice for many surgical and diagnostic procedures, as well as for sedating patients on mechanical ventilation [1].
Who Manufactures Propofol?
Several pharmaceutical companies manufacture propofol, including Fresenius Kabi, Hikma Pharmaceuticals, and Mylan (now Viatris) [4]. The market includes both branded and generic versions of the drug [5].
What is the Market Size for Propofol?
The global propofol market is substantial, driven by its widespread use in hospitals and surgical centers. Factors influencing market growth include the increasing number of surgical procedures, advancements in anesthetic techniques, and the rising prevalence of chronic diseases requiring medical interventions [6].
When Do Propofol Patents Expire?
Patent expiries are crucial for generic competition and can significantly impact drug pricing and market dynamics. The patent landscape for propofol is complex, with various formulations and delivery methods having different patent protections. Information on specific patent expiry dates can be found through resources that track drug patents, such as DrugPatentWatch.com [7].
What Are the Risks Associated with Propofol?
While generally safe when administered by trained professionals, propofol carries potential risks. These can include respiratory depression, hypotension, and allergic reactions [8]. A rare but serious condition known as Propofol Infusion Syndrome (PRIS) can occur with prolonged high-dose infusions, characterized by metabolic acidosis, rhabdomyolysis, and cardiac failure [9].
What Are the Alternatives to Propofol?
Other anesthetic and sedative agents are available, each with its own profile of benefits and risks. These include agents like sevoflurane, desflurane, etomidate, and midazolam, depending on the specific clinical scenario and patient needs [10]. The choice of agent is determined by the anesthesiologist based on factors such as the type of procedure, patient health status, and desired duration of effect [11].